XBIT · XBiotech Inc
United States · RS rating 32 · As of 2026-11-03
| Price | 1.99 USD |
|---|---|
| 1-day change | +3.6% |
| RS rating (overall / 1M / 3M / 12M) | 32 / 38 / 42 / 40 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 20 / 5 / 32 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -22.2% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +32.3% |
| Market cap (USD) | $77.1M |